Dihydroboldenone, most commonly known as 1-testosterone, is a 5alpha reduced form of the steroid boldenone. This lack of 5alpha reduction with the compound allows users to administe it without suffering the negative side effects associated with Dihydroboldenone Cypionate chemical reaction but also eliminates the benefits as well. In fact GP 1-Test Cyp is chemically identical to the Methenolone (GP Prima 100) except for the 1-methylation that is apart of Methenolone. Also GP 1-Test Cyp is structurally similar to GP Bold 200 and less so to Testosterone despite the commonly used name for it, 1-Testosterone.
For this reason some female athletes may be inclined to use GP 1-Test Cyp as well. The potential for development of symptoms of virilization still remain but are not as severe as with synthetic Testosterone or other harsher drugs. This is not to say however that GP 1-Test Cyp is a mild drug. To simplify the explanation of exactly what the drug is, it is to Boldenone as Dihydrotestosterone (DHT) is to Testosterone. This would explain why the effects of GP 1-Test Cyp, both positive and negative, are so dissimilar to those of Boldenone. Like Testosterone and Dihydrotestosterone, a portion of the Boldenone that a user administers converts to Dihydroboldenone. Also similarly, Dihydroboldenone like Dihydrotestosterone does not convert to anything else past that compound.
GP 1-Test Cyp, while not overly androgenic, is a potent anabolic. GP 1-Test Cyp has been demonstrated that the drug binds extremely well and selectively to the androgen receptor and stimulates androgen receptor transactivation of dependent reporter genes. This equates to a drug that possesses the ability to stimulate significant muscle growth while not producing androgenic side effects. GP 1-Test Cyp has been shown to be by far more anabolic then such compounds as Boldenone, Nandrolone, and even Testosterone itself. Obviously this is of great benefit to many athletes and bodybuilders.
Anecdotally some users have indicated that post-injection pain with GP 1-Test Cyp can become an issue for some. Diluting the drug with either another injectable drug or some other type of sterile oil seems to alleviate at least some of this discomfort. The type of ester used does not appear to negate this pain for the users that experience it however.
GP 1-TEST CYP DOSAGE/USE
As for the duration with which GP 1-Test Cyp can be run, due to the mild nature of the drug extended use of the compound can be completed with little in the way of serious complications arising. There are no major issues with hepatoxicity or severe kidney stress and the effect it has on other vital health markers such as blood pressure is slight in the majority of users.
As for specific dosages used with this drug, the low end is primarily thought to be 300-400 mg per week for male users. Like all drugs this number will vary from user to user and also depends on how much of a dramatic effect a user will want to achieve with GP 1-Test Cyp. As for the highest doses that would be worthwhile for users to attempt, this again depends on a number of variables. Doses of one gram per week are not uncommon for some users with others attempting doses in excess of this. It will always come back to how much one is willing to administer and at what point do the positives of increasing your doses begin to be outweighed by the negatives.
For females the usual rules apply with GP 1-Test Cyp as they do with other drugs. If side effects begin to become too severe discontinuation of the drug can begin immediately and low doses should be administered at the beginning of the cycle and can be increased once the tolerance of the user is gauged. Anywhere from 25 to 100 mg per week would be a good starting point for the majority of female users who have little to moderate experience with anabolic steroids.
GP 1-TEST CYP SIDE EFFECTS
GP 1-Test Cyp does not aromatize and therefore estrogenic side effects such as gynecomastia and water retention are not a concern for users. This is partly due to the drug being incapable of 5alpha reduction. Androgenic side effects would also be extremely infrequent for most users as there is little in the way, in terms of attributes of the drug, to produce these. These include such things as acne and hair loss, although GP 1-Test Cyp appears to have the potential to cause prostate enlargement, which is similar in frequency and severity as with that of GP Test Prop 100 (Testosterone Propionate).
With the positive aspects of the lack of aromatization associated with GP 1-Test Cyp also come the negative ones. Fortunately these are primarily limited to such symptoms as lethargy, malaise and possibly a reduction in sex drive. These are caused by a lower ratio of estrogen in comparison to androgens in the body. For the most part however this effect is relatively slight and can be avoided with the use of steroids that do aromatize in conjunction with GP 1-Test Cyp and thus restore a better balance in terms of androgens versus estrogen.
Other common negative side effects associated with the use of anabolic/androgenic steroids are still relatively mild with the use of GP 1-Test Cyp. Of course suppression of the natural Testosterone production of users will occur like with all steroids, however other side effects such as an increase in blood pressure, acne and others are comparably mild and often times non-existent in users, at least as they are directly related to the administration of this drug.
In terms of side effects for women, at moderate to heavy doses symptoms of virilization are likely. These can include such symptoms as clitoral enlargement, body hair growth and deepening of the voice. At lower doses however these side effects should not be a concern for the majority of potential female users.